Minimally Invasive Surgery (MIS) Robotic System Market Size, Share and Trends Analysis - Global - 2025-2031 - Includes: Capital Equipment Market, Disposable and Other Accessories Market and 1 more
Description
Global Minimally Invasive Surgery (MIS) Robotic System Market Report, 2025 Edition
Executive Summary
The global minimally invasive surgery robotic system market was valued at approximately 8.1 billion dollars in 2024. The market is expected to grow at a 15.9 percent CAGR to reach nearly 23 billion dollars by 2031.
This report covers robotic surgical capital systems, disposable instruments, reusable accessories and service and maintenance revenue. It quantifies unit sales, average selling prices, procedure volumes, market values, growth rates and company shares. It also reviews the key trends shaping the shift from open surgery to minimally invasive robotic procedures.
Coverage includes historical data to 2022 and forecasts to 2032. The scope reflects how hospitals, robotic surgery centers and ambulatory surgical facilities evaluate robotic systems for multi-specialty use, procedure expansion, economic value and surgeon recruitment. It also follows the growing global installed base of robotic systems and the rapid expansion in procedure numbers.
Market Overview
Robotic-assisted surgery has become one of the fastest growing segments in the surgical device market. While early adoption began in specialized centers and high-profile academic hospitals, robotic platforms are now entering a wider range of surgical environments due to improvements in system versatility, reduced device footprints and expanding clinical indications.
Intuitive Surgical has historically dominated this market with its da Vinci platform. However, emerging competitors are becoming more active across global markets. Systems from CMR Surgical, Medtronic, SS Innovations and Distalmotion have strengthened competition in both capital equipment and procedure-based consumables.
As regulatory approvals expand for new indications, robotic systems are being used for a broader range of minimally invasive procedures, including general surgery, gynecology, urology, thoracic surgery, colorectal surgery, bariatric surgery and select cardiothoracic applications. Growth in procedure volume remains the strongest market driver, as system utilization increases revenues from disposables and accessories.
The global shift toward minimally invasive care continues to motivate hospitals to invest in robotic systems. Patients increasingly expect shorter recovery times, reduced postoperative pain and smaller incisions. Robotic-assisted MIS procedures can meet these expectations while improving precision and reducing risk.
Financing models are also changing. Hospitals can now acquire robotic systems through direct purchases, managed service agreements, leasing programs and per-procedure models. These flexible arrangements make it easier for mid-sized hospitals and ambulatory centers to adopt robotic technology without the high upfront capital investment.
Although regulatory approvals remain complex and time-intensive, robotic platforms are steadily progressing through global registration processes. As more systems receive clearance for additional indications, the number of eligible procedures will expand, supporting long-term market growth.
Market Drivers
Revenue from Alternate Sources
The strongest driver of long-term market expansion is the revenue generated from procedures. Disposable instruments, reusable accessories and ongoing service contracts make up the majority of revenue in the global MIS robotic system market.
With over 2.6 million da Vinci procedures performed globally in 2024, Intuitive Surgical has demonstrated that a growing installed base directly accelerates recurring revenue. As more robotic systems are adopted worldwide, the volume of procedures and the demand for robotic consumables will rise accordingly.
Manufacturers also benefit from upgrades, software subscriptions and service agreements tied to system maintenance. As hospitals update systems to newer models or integrate additional specialty modules, vendors increase their long-term revenue potential.
Recruitment Competition
Hospitals face increasing pressure to attract top surgeons and maintain high clinical standards. Robotic-assisted surgery plays a critical role in this competition.
Surgeons who specialize in MIS often prefer hospitals with advanced robotic platforms. As a result, hospitals seeking to recruit or retain experienced surgical talent must invest in the latest robotic technologies. This has prompted many facilities to update older systems or purchase additional units to meet internal demand.
Robotic systems also serve as marketing tools for hospitals. Facilities promote their investment in high-tech robotic surgery to potential patients, highlighting improved safety, reduced recovery times and enhanced precision.
Clinical Benefits
Robotic-assisted surgery enhances surgeon dexterity, precision and visualization. These advantages can reduce complications, decrease the likelihood of revision surgery and shorten patient recovery times.
The clinical benefits of robotic-assisted MIS include:
improved surgical accuracy
lower conversion rates to open surgery
decreased blood loss
shorter hospital stays
fewer postoperative complications
Intuitive Surgical has focused heavily on procedure-specific outcomes in its marketing strategy. By targeting procedures where robotic-assisted MIS improves recovery time and reduces complications, manufacturers strengthen the clinical and economic value proposition for hospitals.
As clinical evidence builds across multiple specialties, robotic-assisted MIS will continue to replace conventional laparoscopic and open procedures.
Growing Installed Base
Each robotic system added to a region increases the long-term need for consumables and service support. Because robotic procedures require proprietary instruments, hospitals become long-term customers once systems are installed.
High utilization rates and expanding indications continue to reinforce demand for replacement tools and accessories, creating an ongoing revenue cycle. This recurring revenue model supports the rapid growth seen across global regions.
Market Limiters
Cost of Using Robotic Systems
Robotic-assisted MIS remains significantly more expensive than conventional non-robotic surgery. High capital acquisition costs, service fees and proprietary instrument costs can limit adoption. Many hospitals must choose between multiple competing MIS technologies when budgeting.
Cost limitations include:
system purchase prices
training expenses
service and maintenance contracts
per-procedure consumable costs
Media attention has also questioned the cost-effectiveness of certain robotic procedures, particularly when clinical outcomes are similar to traditional laparoscopic techniques. These concerns can delay purchases, especially in regions with strict cost-control policies.
Training Period
Robotic systems require extensive surgeon training and staff preparation. The learning curve can slow adoption, as surgeons may need multiple procedures to feel comfortable using a robotic system.
Training challenges include:
limited availability of training facilities
varying comfort levels among surgeons
extended time to achieve proficiency
need for trained support staff
Hospitals with limited training budgets or limited access to robotic experts may delay system purchases. In facilities with low procedural volume, utilization may remain low due to a lack of trained personnel.
Regulatory Barriers
Regulatory approval processes differ by country and can significantly slow product launches. Manufacturers seeking clearance for new systems or expanded indications must navigate complex and increasingly stringent requirements.
Regulatory bodies, including the FDA and foreign authorities, continue to tighten standards on safety, performance and reporting. These requirements extend the timeline from prototype to market, delaying revenue for manufacturers and slowing global adoption.
Market Coverage and Data Scope
Quantitative Coverage
market size
market shares
market forecasts
market growth rates
units sold
average selling prices
Qualitative Coverage
market growth trends
market limiters
technology trends
company profiles
mergers and acquisitions
product portfolios
regulatory and recall activity
procedure volumes by region
Time Frame
base year: 2024
historical data: 2022 to 2024
forecasts: 2025 to 2032
Data Sources
interviews with industry leaders
hospital purchasing data
regulatory filings
physician specialty data
import and export statistics
iData’s internal forecasting database
Market Segmentation Summary
Minimally Invasive Surgery Robotic Systems by Revenue Type
Capital Equipment
Disposables and Other Accessories
Service and Maintenance Revenue
Competitive Analysis
Intuitive Surgical
Intuitive Surgical was the dominant competitor in the global MIS robotic system market in 2024. The company markets the da Vinci Xi, da Vinci X and da Vinci SP systems. It also offers the Ion robotic platform for minimally invasive lung biopsies.
Intuitive maintains the largest global installed base and the highest utilization rates. Its strong brand, continuous software updates and robust training programs support its leadership position.
In 2024, the company reported 362 new system placements for its da Vinci 5 system alone. Intuitive’s strategy of outcome-focused marketing and multi-specialty expansion continues to fuel rapid growth.
CMR Surgical
CMR Surgical, based in the United Kingdom, was one of the emerging competitors in 2024. The company has performed more than 27,000 procedures with its Versius robotic system across Europe, Latin America, Asia and the Middle East.
CMR obtained CE mark approval in 2019 and expanded its regulatory footprint in 2024 by receiving FDA clearance for Versius with an initial gallbladder removal indication. This milestone positions CMR for accelerated growth in the United States.
Medtronic
Medtronic entered the robotic-assisted MIS market in 2021 with the Hugo RAS platform. Hugo is commercially available in several regions worldwide but remains investigational in the United States.
Medtronic’s reputation as a major medical device manufacturer and its established global distribution network position it as an important long-term competitor. As Hugo obtains additional approvals and expands its procedural indications, Medtronic is likely to increase its share of the MIS robotic system market.
Technology and Practice Trends
Growth in single-port robotic platforms
Increasing use of robotic systems in ambulatory surgery centers
Expansion of robotic eligibility into additional surgical specialties
Transition to modular and portable robotic platforms
Growth in AI-enhanced visualization and procedure guidance
Broader use of robotics in general surgery and thoracic surgery
Greater focus on cost-effective systems for emerging markets
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Why This Report
Identify the fastest-growing revenue sources in the MIS robotic system market
Understand how emerging competitors are gaining share
Assess the impact of flexible financing models on adoption
Evaluate how surgeon recruitment competition shapes purchase decisions
Review key clinical benefits that influence robotic utilization
Analyze regulatory barriers and training constraints
Compare capital equipment, disposables and service revenue trends
Understand where global procedure growth is accelerating
The Global MIS Robotic System Market Report from iData Research provides detailed sizing, competitive positioning and long-term forecasts to support strategic planning and market entry decisions.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows
Executive Summary
The global minimally invasive surgery robotic system market was valued at approximately 8.1 billion dollars in 2024. The market is expected to grow at a 15.9 percent CAGR to reach nearly 23 billion dollars by 2031.
This report covers robotic surgical capital systems, disposable instruments, reusable accessories and service and maintenance revenue. It quantifies unit sales, average selling prices, procedure volumes, market values, growth rates and company shares. It also reviews the key trends shaping the shift from open surgery to minimally invasive robotic procedures.
Coverage includes historical data to 2022 and forecasts to 2032. The scope reflects how hospitals, robotic surgery centers and ambulatory surgical facilities evaluate robotic systems for multi-specialty use, procedure expansion, economic value and surgeon recruitment. It also follows the growing global installed base of robotic systems and the rapid expansion in procedure numbers.
Market Overview
Robotic-assisted surgery has become one of the fastest growing segments in the surgical device market. While early adoption began in specialized centers and high-profile academic hospitals, robotic platforms are now entering a wider range of surgical environments due to improvements in system versatility, reduced device footprints and expanding clinical indications.
Intuitive Surgical has historically dominated this market with its da Vinci platform. However, emerging competitors are becoming more active across global markets. Systems from CMR Surgical, Medtronic, SS Innovations and Distalmotion have strengthened competition in both capital equipment and procedure-based consumables.
As regulatory approvals expand for new indications, robotic systems are being used for a broader range of minimally invasive procedures, including general surgery, gynecology, urology, thoracic surgery, colorectal surgery, bariatric surgery and select cardiothoracic applications. Growth in procedure volume remains the strongest market driver, as system utilization increases revenues from disposables and accessories.
The global shift toward minimally invasive care continues to motivate hospitals to invest in robotic systems. Patients increasingly expect shorter recovery times, reduced postoperative pain and smaller incisions. Robotic-assisted MIS procedures can meet these expectations while improving precision and reducing risk.
Financing models are also changing. Hospitals can now acquire robotic systems through direct purchases, managed service agreements, leasing programs and per-procedure models. These flexible arrangements make it easier for mid-sized hospitals and ambulatory centers to adopt robotic technology without the high upfront capital investment.
Although regulatory approvals remain complex and time-intensive, robotic platforms are steadily progressing through global registration processes. As more systems receive clearance for additional indications, the number of eligible procedures will expand, supporting long-term market growth.
Market Drivers
Revenue from Alternate Sources
The strongest driver of long-term market expansion is the revenue generated from procedures. Disposable instruments, reusable accessories and ongoing service contracts make up the majority of revenue in the global MIS robotic system market.
With over 2.6 million da Vinci procedures performed globally in 2024, Intuitive Surgical has demonstrated that a growing installed base directly accelerates recurring revenue. As more robotic systems are adopted worldwide, the volume of procedures and the demand for robotic consumables will rise accordingly.
Manufacturers also benefit from upgrades, software subscriptions and service agreements tied to system maintenance. As hospitals update systems to newer models or integrate additional specialty modules, vendors increase their long-term revenue potential.
Recruitment Competition
Hospitals face increasing pressure to attract top surgeons and maintain high clinical standards. Robotic-assisted surgery plays a critical role in this competition.
Surgeons who specialize in MIS often prefer hospitals with advanced robotic platforms. As a result, hospitals seeking to recruit or retain experienced surgical talent must invest in the latest robotic technologies. This has prompted many facilities to update older systems or purchase additional units to meet internal demand.
Robotic systems also serve as marketing tools for hospitals. Facilities promote their investment in high-tech robotic surgery to potential patients, highlighting improved safety, reduced recovery times and enhanced precision.
Clinical Benefits
Robotic-assisted surgery enhances surgeon dexterity, precision and visualization. These advantages can reduce complications, decrease the likelihood of revision surgery and shorten patient recovery times.
The clinical benefits of robotic-assisted MIS include:
improved surgical accuracy
lower conversion rates to open surgery
decreased blood loss
shorter hospital stays
fewer postoperative complications
Intuitive Surgical has focused heavily on procedure-specific outcomes in its marketing strategy. By targeting procedures where robotic-assisted MIS improves recovery time and reduces complications, manufacturers strengthen the clinical and economic value proposition for hospitals.
As clinical evidence builds across multiple specialties, robotic-assisted MIS will continue to replace conventional laparoscopic and open procedures.
Growing Installed Base
Each robotic system added to a region increases the long-term need for consumables and service support. Because robotic procedures require proprietary instruments, hospitals become long-term customers once systems are installed.
High utilization rates and expanding indications continue to reinforce demand for replacement tools and accessories, creating an ongoing revenue cycle. This recurring revenue model supports the rapid growth seen across global regions.
Market Limiters
Cost of Using Robotic Systems
Robotic-assisted MIS remains significantly more expensive than conventional non-robotic surgery. High capital acquisition costs, service fees and proprietary instrument costs can limit adoption. Many hospitals must choose between multiple competing MIS technologies when budgeting.
Cost limitations include:
system purchase prices
training expenses
service and maintenance contracts
per-procedure consumable costs
Media attention has also questioned the cost-effectiveness of certain robotic procedures, particularly when clinical outcomes are similar to traditional laparoscopic techniques. These concerns can delay purchases, especially in regions with strict cost-control policies.
Training Period
Robotic systems require extensive surgeon training and staff preparation. The learning curve can slow adoption, as surgeons may need multiple procedures to feel comfortable using a robotic system.
Training challenges include:
limited availability of training facilities
varying comfort levels among surgeons
extended time to achieve proficiency
need for trained support staff
Hospitals with limited training budgets or limited access to robotic experts may delay system purchases. In facilities with low procedural volume, utilization may remain low due to a lack of trained personnel.
Regulatory Barriers
Regulatory approval processes differ by country and can significantly slow product launches. Manufacturers seeking clearance for new systems or expanded indications must navigate complex and increasingly stringent requirements.
Regulatory bodies, including the FDA and foreign authorities, continue to tighten standards on safety, performance and reporting. These requirements extend the timeline from prototype to market, delaying revenue for manufacturers and slowing global adoption.
Market Coverage and Data Scope
Quantitative Coverage
market size
market shares
market forecasts
market growth rates
units sold
average selling prices
Qualitative Coverage
market growth trends
market limiters
technology trends
company profiles
mergers and acquisitions
product portfolios
regulatory and recall activity
procedure volumes by region
Time Frame
base year: 2024
historical data: 2022 to 2024
forecasts: 2025 to 2032
Data Sources
interviews with industry leaders
hospital purchasing data
regulatory filings
physician specialty data
import and export statistics
iData’s internal forecasting database
Market Segmentation Summary
Minimally Invasive Surgery Robotic Systems by Revenue Type
Capital Equipment
Disposables and Other Accessories
Service and Maintenance Revenue
Competitive Analysis
Intuitive Surgical
Intuitive Surgical was the dominant competitor in the global MIS robotic system market in 2024. The company markets the da Vinci Xi, da Vinci X and da Vinci SP systems. It also offers the Ion robotic platform for minimally invasive lung biopsies.
Intuitive maintains the largest global installed base and the highest utilization rates. Its strong brand, continuous software updates and robust training programs support its leadership position.
In 2024, the company reported 362 new system placements for its da Vinci 5 system alone. Intuitive’s strategy of outcome-focused marketing and multi-specialty expansion continues to fuel rapid growth.
CMR Surgical
CMR Surgical, based in the United Kingdom, was one of the emerging competitors in 2024. The company has performed more than 27,000 procedures with its Versius robotic system across Europe, Latin America, Asia and the Middle East.
CMR obtained CE mark approval in 2019 and expanded its regulatory footprint in 2024 by receiving FDA clearance for Versius with an initial gallbladder removal indication. This milestone positions CMR for accelerated growth in the United States.
Medtronic
Medtronic entered the robotic-assisted MIS market in 2021 with the Hugo RAS platform. Hugo is commercially available in several regions worldwide but remains investigational in the United States.
Medtronic’s reputation as a major medical device manufacturer and its established global distribution network position it as an important long-term competitor. As Hugo obtains additional approvals and expands its procedural indications, Medtronic is likely to increase its share of the MIS robotic system market.
Technology and Practice Trends
Growth in single-port robotic platforms
Increasing use of robotic systems in ambulatory surgery centers
Expansion of robotic eligibility into additional surgical specialties
Transition to modular and portable robotic platforms
Growth in AI-enhanced visualization and procedure guidance
Broader use of robotics in general surgery and thoracic surgery
Greater focus on cost-effective systems for emerging markets
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Why This Report
Identify the fastest-growing revenue sources in the MIS robotic system market
Understand how emerging competitors are gaining share
Assess the impact of flexible financing models on adoption
Evaluate how surgeon recruitment competition shapes purchase decisions
Review key clinical benefits that influence robotic utilization
Analyze regulatory barriers and training constraints
Compare capital equipment, disposables and service revenue trends
Understand where global procedure growth is accelerating
The Global MIS Robotic System Market Report from iData Research provides detailed sizing, competitive positioning and long-term forecasts to support strategic planning and market entry decisions.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows
Table of Contents
87 Pages
- Research Methodology
- Step 1: Project Initiation & Team Selection
- Step 2: Prepare Data Systems And Perform Secondary Research
- Step 3: Preparation For Interviews & Questionnaire Design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecast And Analysis
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review And Market Release
- Step 9: Customer Feedback And Market Monitoring
- Disease Overview
- 2.1 Medical Conditions
- 2.1.1 Cardiac Conditions
- 2.1.1.1 Coronary Artery Disease
- 2.1.1.2 Mitral Valve Prolapse
- 2.1.2 Colorectal Conditions
- 2.1.2.1 Colorectal Cancer
- 2.1.2.2 Diverticulitis
- 2.1.2.3 Inflammatory Bowel Disease
- 2.1.3 Digestive Tract Conditions
- 2.1.3.1 Achalasia
- 2.1.3.2 Gallbladder Attack
- 2.1.3.3 Gastroesophageal Reflux Disease
- 2.1.3.4 Hernia
- 2.1.3.5 Stomach Cancer
- 2.1.4 Ear, Nose And Throat (Ent) Conditions
- 2.1.4.1 Cholesteatomas
- 2.1.4.2 Chronic Sinusitis
- 2.1.4.3 Otitis Media
- 2.1.4.4 Otosclerosis
- 2.1.4.5 Tonsillitis
- 2.1.5 Gynecological Conditions
- 2.1.5.1 Endometriosis
- 2.1.5.2 Gynecological Cancers
- 2.1.5.3 Menorrhagia
- 2.1.5.4 Pelvic Prolapse
- 2.1.5.5 Uterine Fibroids
- 2.1.6 Neurosurgical Conditions
- 2.1.6.1 Brain Tumor
- 2.1.6.2 Communicating Hydrocephalus
- 2.1.6.3 Hydrocephalus
- 2.1.6.4 Intracranial Aneurysm
- 2.1.6.5 Intracranial Atherosclerosis Disease
- 2.1.6.6 Intracranial Pressure
- 2.1.6.7 Non-Communicating Hydrocephalus
- 2.1.6.8 Normal Pressure Hydrocephalus
- 2.1.7 Orthopedic Conditions
- 2.1.7.1 Arthritis
- 2.1.7.2 Fractures
- 2.1.7.3 Osteoporosis
- 2.1.8 Spinal Conditions
- 2.1.8.1 Herniated Disc
- 2.1.8.2 Kyphosis
- 2.1.8.3 Scoliosis
- 2.1.8.4 Spinal Stenosis
- 2.1.8.5 Spondylosis
- 2.1.9 Urological Conditions
- 2.1.9.1 Benign Prostatic Hyperplasia (Bph)
- 2.1.9.2 Bladder Cancer
- 2.1.9.3 Kidney Cancer
- 2.1.9.4 Prostate Cancer
- Minimally Invasive Surgery Robotic System Market
- 10.1 Executive Summary
- 10.1.1 Global Minimally Invasive Surgery Robotic System Market Overview
- 10.1.2 Competitive Analysis
- 10.1.3 Market Segmentation
- 10.1.4 Regions Included
- 10.2 Introduction
- 10.3 Procedure Numbers
- 10.4 Market Overview
- 10.4.1 By Segment
- 10.4.2 By Region
- 10.5 Market Analysis And Forecast
- 10.5.1 System Placement
- 10.5.2 Mis Robotic Capital Equipment Market
- 10.5.3 Mis Robotic Disposables And Other Accessories Market
- 10.5.4 Mis Robotic System Service And Maintenance Revenue Market
- 10.6 Drivers And Limiters
- 10.6.1 Market Drivers
- 10.6.2 Market Limiters
- 10.7 Competitive Market Share Analysis
- 10.7.1 Emerging Competitors
- Abbreviations
- Chart 10-1: Minimally Invasive Surgery Robotic System Market, Global, 2024 & 2031
- Chart 10-2: Minimally Invasive Surgery Robotic System Procedures, Global, 2024
- Chart 10-3: Minimally Invasive Robotic-Assisted Surgery Procedures by Region, Global, 2021 – 2031
- Chart 10-4: Minimally Invasive Surgery Robotic System Market by Segment, Global, 2021 – 2031
- Chart 10-5: Minimally Invasive Surgery Robotic System Market by Region, Global, 2021 – 2031
- Chart 10-6: Leading Competitors, Minimally Invasive Surgery Robotic System Market, Global, 2024
- Figure 10-1: Minimally Invasive Surgery Robotic System Market Segmentation
- Figure 10-2: Minimally Invasive Surgery Robotic System Regions Covered, Global (1 of 2)
- Figure 10-3: Minimally Invasive Surgery Robotic System Regions Covered, Global (2 of 2)
- Figure 10-4: Minimally Invasive Robotic-Assisted Surgery Procedures by Region, Global, 2021 – 2031
- Figure 10-5: Minimally Invasive Robotic-Assisted Surgery Procedures by Country, North America, 2021 – 2031
- Figure 10-6: Minimally Invasive Robotic-Assisted Surgery Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
- Figure 10-7: Minimally Invasive Robotic-Assisted Surgery Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
- Figure 10-8: Minimally Invasive Robotic-Assisted Surgery Procedures by Country, Western Europe, 2021 – 2031
- Figure 10-9: Minimally Invasive Robotic-Assisted Surgery Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
- Figure 10-10: Minimally Invasive Robotic-Assisted Surgery Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
- Figure 10-11: Minimally Invasive Robotic-Assisted Surgery Procedures by Country, Middle East, 2021 – 2031
- Figure 10-12: Minimally Invasive Robotic-Assisted Surgery Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
- Figure 10-13: Minimally Invasive Robotic-Assisted Surgery Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
- Figure 10-14: Minimally Invasive Robotic-Assisted Surgery Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
- Figure 10-15: Minimally Invasive Robotic-Assisted Surgery Procedures by Country, Africa, 2021 – 2031
- Figure 10-16: Minimally Invasive Surgery Robotic System Market by Segment, Global, 2021 – 2031 (US$M)
- Figure 10-17: Minimally Invasive Surgery Robotic System Market by Region, Global, 2021 – 2031 (US$M)
- Figure 10-18: System Placement, MIS Robotic System Market, Global, 2021 – 2031
- Figure 10-19: Total Systems Placed, MIS Robotic System Market, Global, 2021 – 2031
- Figure 10-20: System Leased or Placed under Financial Arrangement, MIS Robotic System Market, Global, 2021 – 2031
- Figure 10-21: MIS Robotic Capital Equipment Market, Global, 2021 – 2031
- Figure 10-22: Systems Sold by Region, MIS Robotic Capital Equipment Market, Global, 2021 – 2031
- Figure 10-23: Installed Base by Region, MIS Robotic Capital Equipment Market, Global, 2021 – 2031
- Figure 10-24: Average Selling Price by Region, MIS Robotic Capital Equipment Market, Global, 2021 – 2031 (US$)
- Figure 10-25: Market Value by Region, MIS Robotic Capital Equipment Market, Global, 2021 – 2031 (US$M)
- Figure 10-26: MIS Robotic Disposables and Other Accessories Market, Global, 2021 – 2031
- Figure 10-27: Procedures by Region, MIS Robotic Disposables and Other Accessories Market, Global, 2021 – 2031
- Figure 10-28: Average Selling Price by Region, MIS Robotic Disposables and Other Accessories Market, Global, 2021 – 2031 (US$)
- Figure 10-29: Market Value by Region, MIS Robotic Disposables and Other Accessories Market, Global, 2021 – 2031 (US$M)
- Figure 10-30: MIS Robotic System Service and Maintenance Revenue Market, Global, 2021 – 2031
- Figure 10-31: Installed Base Serviced by Region, MIS Robotic System Service and Maintenance Revenue Market, Global, 2021 – 2031
- Figure 10-32: Average Selling Price by Region, MIS Robotic System Service and Maintenance Revenue Market, Global, 2021 – 2031
- Figure 10-33: Market Value by Region, MIS Robotic System Service and Maintenance Revenue Market, Global, 2021 – 2031
- Figure 10-34: Leading Competitors, Minimally Invasive Surgery Robotic System Market, Global, 2024
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
